Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Report: Russian military pressuring students to work as drone pilots - 2Porsche May Kill the Electric Boxster Before It Ever Arrives
- 3Stolen Renoir, Cézanne and Matisse were probably uninsured, market sources say
- 4Dental Embed Developments: Upsetting Current Dentistry
- 5Vote In favor of Your Favored Kind Of Organic product
- Best Getaway destination: Ocean side, Mountain, or City
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Best Wellness Tracker Keep You On target
- Uranus's small moons are dark, red, and water-poor
- One dead, six wounded in various crime-related shootings in Israel over the weekend
- Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus
- Vote In favor of Your Favored Web-based Visual depiction Administration
- Vote in favor of your #1 sort of juice
- New electric car registrations rise sharply in Germany in March
